Otosyphilis in HIV-coinfected individuals: A case series from Toronto, Canada

AIDS Patient Care and STDs

Volumn 22, Issue 3, 2008, Pages 213-219

  Mishra, Sharmistha ^a,b   Walmsley, Sharon Lynn ^a,b   Loutfy, Mona Rafik ^b,c   Kaul, Rupert ^a,b   Logue, Kenneth John ^a,b   Gold, Wayne Lawrence ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MAPLE LEAF MEDICAL CLINIC   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; PENICILLIN G; PREDNISONE; PROBENECID; STEROID;

ADULT; ARTICLE; AUDIOMETRY; CANADA; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; NEUROSYPHILIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SEROLOGY; SYPHILIS; TINNITUS; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; EAR DISEASES; FEMALE; HEARING LOSS; HIV INFECTIONS; HIV-1; HUMANS; MALE; ONTARIO; PENICILLIN G, BENZATHINE; SYPHILIS; TREATMENT OUTCOME; URBAN POPULATION;

EID: 40749141990     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0019     Document Type: Article

References (41)

1. Sexual Health and Sexually Transmitted Infections Section, Public Health Agency of Canada. 2004 Canadian Sexually Transmitted Infections Surveillance Report: Pre-release. www.phac-aspc.gc.ca/std-mts/stddata_pre06_04/index.html (Last accessed January 31, 2008).
2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2005. Atlanta, GA: U.S. Department of Health and Human Services, December 2006. www.cdc.gov/std/stats/default.htm (Last accessed January 31, 2008).
3. Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis in persons with HIV in the United States, 2002. Sex Transm Dis 2005;32:265-269.
4. Centers for Disease Control and Prevention. Recommendations for Public Health Surveillance of Syphilis in the United States, Atlanta, GA: U.S. Department of Health and Human Services, March 2003. www.cdc.gov/std/Syphilis/ default.htm (Last accessed January 31, 2008).
5. Golden MR, Marra CM, Holmes KK. Update on syphilis: Resurgence of an old problem. JAMA 2003;290:1510-1514.
6. Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis 2006:42:337-345.
7. Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: The new epidemic. Eye [serial online]. 2006:20:703-705. (Last accessed December 9, 2006).
8. Sabbatani S, Manfredi R, Attard L, Salfi N. Secondary syphilis presenting with acute severe hepatic involvement in a patient with undiagnosed HIV disease. AIDS Patient Care STDs 2005;19:545-549.
9. Guerrero AF, Straight TM, Eastone J, Spooner K. Gastric syphilis in an HIV-infected patient. AIDS Patient Care STDs 2005:19:281-285.
10. Hendershot EL. Leutic deafness. Otolaryngol Clin North Am 1978;11:43-46.
11. Karmody CS, Schuknecht HF. Deafness in congenital syphilis. Arch Otolaryngol 1966;83:44-53.
12. Becker GD. Late syphilitic hearing loss: A diagnostic and therapeutic dilemma. Laryngoscope 1979;89:1273-1288.
13. Wong RT, Lepore ML, Burch GR, Henderson RL. Luetic hearing loss. Laryngoscope 1977;87:1765-1769.
14. Steckelberg JM, McDonald TJ. Otologic involvement in late syphilis. Laryngoscope 1984;94:753-757.
15. McNulty JS, Fassett RL. Syphilis: An otolaryngologic perspective. Laryngoscope 1981;91:889-905.
16. Wilson W, Zoller M. Electronystagmography in congenital and acquired syphilitic otitis. Ann Otol Rhinol Laryngol 1981;90:21-24.
17. Chan YM, Adams DA, Kerr AG. Syphilitic labrinthitis-an update. J Laryngol Otol 1995;109:719-725.
18. Pillsbury HC, Shea JJ. Leutic hydrops - Diagnosis and therapy. Laryngoscope 1979;89:1135-1143.
19. Zoller M, Wilson WR, Nadol JB. Treatment of syphilitic hearing loss: Combined penicillin and steroid therapy in 29 patients. Ann Otol Rhinol Laryngol 1979;88:161-5.
20. Dobbin JM, Perkins JH, Farmington CT. Otosyphilis and hearing loss: Response to penicillin and steroid therapy. Laryngoscope 1983;93:1540-1542.
21. Fitzgerald DC, Mark AS. Sudden hearing loss: Frequency of abnormal findings on contrast-enhanced MR studies. Am J Neuroradiol 1998;19:1433-1436.
22. Balkany TJ, Dans PE. Reversible sudden deafness in early acquired syphilis. Arch Otolaryngol 1978;104:66-68.
23. Vercoe GS. The effect of early syphilis on the inner ear and auditory nerves. J Laryngol Otol 1976;90:853-861.
24. Tamari M, Itkin P. Penicillin and syphilis of the ear. Eye Ear Nose Throat Mon 1951;30:252-261.
25. Kassutto S, Doweiko JP. Syphilis in the HIV era. Emerg Infect Dis 2004;10:1471-1473.
26. Smith ME, Canalis RF. Otologic manifestations of AIDS: The otosyphilis connection. Laryngoscope 1989;99:365-372.
27. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with human immunodeficiency virus. N Engl J Med 1987;316:1569-1572.
28. Katz DA, Berger JR. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 1989;46:895-898.
29. Flood JM, Weinstock HS, Guroy ME, Bayne L, Simon RP, Bolan G. Neurosyphilis during the AIDS epidemic, San Francisco, 1985-1992. J Infect Dis 1998;177:931-940.
30. Little JP, Gardner G, Acker JD, Land MA. Otosyphilis in a patient with human immunodeficiency virus: Internal auditory canal gumma. Otolaryngol Head Neck Surg 1995;112:488-492.
31. Fernandez-Guerrero ML, Miranda C, Cenjor C, Sanabria F. The treatment of neurosyphilis in patients with HIV infection. JAMA 1988;259:1495-1496.
32. Walter T, Lebouche B, Miailhes P, et al. Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis 2006;43:787-790.
33. Linstrom CJ, Gleich LL. Otosyphilis: Diagnostic and therapeutic update. J Otolaryngol 1993;22:401-408.
34. Rodgers CA, Murphy S. Diagnosis of neurosyphilis: appraisal of clinical caseload. Genitourin Med 1997;73:528-532.
35. Willcox RR, Goodwin PG. Nerve deafness in early syphilis. Br J Vener Dis 1971;47:401-406.
36. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines: 2006. www.cdc.gov/std/treatment/2006/toc.htm (Last accessed January 31, 2008).
37. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: Asociation with clinical and laboratory features. J Infect Dis 2004;189;369-376.
38. Kerr AG, Smyth GDL, Cinnamond MJ. Congenital syphilitic deafness. J Laryngol Otol 1973;87:1-12.
39. Wiet RJ, Milko DA. Isolation of the spirochetes in the perilymph despite prior antisyphilitic therapy. Arch Otolaryngol 1975;101:104-106.
40. Dawkins RS, Sharp M, Morrison AW. Steroid treatment in congenital syphilitic deafness. J Laryngol Otol 1968;82:1005-1006.
41. Klemm E, Wollina U. Otosyphilis: eport on six cases. J Eur Acad Dermatol Venereol 2004;18:429-434.